[1]刘先姜,王雅,王娜,等.柴芍六君子汤加减治疗非酒精性脂肪性肝炎肝郁脾虚证临床研究[J].中国中医药信息杂志,2021,28(1):113-117.[doi:10.19879/j.cnki.1005-5304.202006364]
 LIU Xianjiang,WANG Ya,WANG Na,et al.Clinical Study on Modified Chaishao Liujunzi Decoction in Treatment of Nonalcoholic Steatohepatitis with Liver Stagnation and Spleen Deficiency Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2021,28(1):113-117.[doi:10.19879/j.cnki.1005-5304.202006364]
点击复制

柴芍六君子汤加减治疗非酒精性脂肪性肝炎肝郁脾虚证临床研究

参考文献/References:

[1] FRIEDMAN S L, NEUSCHWANDER-TETRI B A, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nature Medicine,2018,24(7):908-922.

[2] GOH G B, MCCULLOUGH A J. Natural history of nonalcoholic fatty liver disease[J]. Dig Dis Sci,2016,61(5):1226-1233.

[3] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186.

[4] 常彬霞,李保森,邹正升.《2016年欧洲肝病学会、欧洲糖尿病学会和欧洲肥胖学会临床实践指南:非酒精性脂肪性肝病》摘译[J].临床肝胆病杂志,2016,32(8):1450-1454.

[5] 中华中医药学会脾胃病分会.非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(12):2270-2274.

[6] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:143-151,364-366.

[7] 冷雪君,颜学兵.非酒精性脂肪性肝炎的药物治疗进展[J].世界华人消化杂志,2017,25(18):1645-1654.

[8] 郑颖,孙华胜,毛乾国.中医防治非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(15):25-28.

[9] 李德恒,吴会晓,严海艺,等.郭朋主任医师治疗非酒精性脂肪性肝病的经验[J].中西医结合肝病杂志,2020,30(2):159-160.

[10] 周强,张声生.张声生运用调肝理脾法辨治非酒精性脂肪性肝病经验[J].世界中西医结合杂志,2016,11(4):470-472,554.

[11] 邹俊锋.升降汤对肝郁脾虚型非酒精性脂肪性肝炎患者肝功能及疗效的影响[J].实用中医内科杂志,2019,33(9):57-59.

[12] 孙超,范建高.中外非酒精性脂肪性肝病诊疗指南解读[J].中国实用内科杂志,2019,39(3):235-238.

[13] 王东旭,王云,吴县斌,等.多烯磷脂酰胆碱联合维生素E治疗非酒精性脂肪肝的有效性及安全性探讨[J].中国医药导刊,2017,19(12):1348-1351.

[14] 罗利婷,张霞,牛俊奇.维生素E能改善非酒精性脂肪性肝炎和晚期肝硬化患者的免移植生存率和失代偿发生率[J].临床肝胆病杂志,2019, 35(2):358.

相似文献/References:

[1]张晓东,凌琪华,聂红明,等.慢性乙型肝炎肝郁脾虚证的logistic回归及判别分析[J].中国中医药信息杂志,2009,16(9):23.
 ZHANG Xiao-dong,LING Qi-hua,NIE Hong-ming,et al.Logistic Regression and Discriminant Analysis of Liver Depression and Spleen Asthenia Syndrome of Chronic Hepatitis B[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):23.
[2]曹立华,彭勋,王鑫国,等.清脂益肝汤治疗非酒精性脂肪性肝炎临床观察[J].中国中医药信息杂志,2008,15(8):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(1):64.
[3]刘建鸿,岳嘉,段永强,等.肝郁脾虚证模型大鼠免疫细胞分化和增殖变化规律研究[J].中国中医药信息杂志,2013,20(1):43.[doi:10.3969/j.issn.1005-5304.2013.01.016]
 LIU Jian-hong,YUE Jia,DUAN Yong-qiang,et al.Rule of Proliferation and Differentiation of Immune Cells in Rats Model of Liver Depression and Spleen Deficiency[J].zhongguo zhongyiyao xinxi zazhi,2013,20(1):43.[doi:10.3969/j.issn.1005-5304.2013.01.016]
[4]吴永红,郑国荣.四磨汤口服液联合复方谷氨酰胺肠溶胶囊治疗腹泻型肠易激综合征临床研究[J].中国中医药信息杂志,2013,20(8):11.[doi:10.3969/j.issn.1005-5304.2013.08.005]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(1):11.[doi:10.3969/j.issn.1005-5304.2013.08.005]
[5]李享,彭美哲,王思玉,等.肝郁脾虚证研究现状[J].中国中医药信息杂志,2013,20(11):107.[doi:10.3969/j.issn.1005-5304.2013.11.049]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(1):107.[doi:10.3969/j.issn.1005-5304.2013.11.049]
[6]李杰,王新月.健脾疏肝丸联合水飞蓟宾胶囊治疗非酒精性脂肪性肝炎临床观察[J].中国中医药信息杂志,2010,17(1):68.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(1):68.
[7]岳嘉,刘建鸿,程晓丽,等.肝郁脾虚证模型大鼠红细胞和促红细胞生成素变化规律研究[J].中国中医药信息杂志,2015,22(3):77.[doi:10.3969/j.issn.1005-5304.2015.03.020]
 YUE Jia,LIU Jian-hong,CHENG Xiao-li,et al.Changes of Red Blood Cell and Erythropoietin in Rat Models with Liver Depression and Spleen Deficiency Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2015,22(1):77.[doi:10.3969/j.issn.1005-5304.2015.03.020]
[8]周福生,吴文江.肠易激综合征肝郁脾虚证与脑肠肽相关性研究思路[J].中国中医药信息杂志,2004,11(2):183.
[9]马燕花,杨少军,师霞,等.慈菇消脂丸对非酒精性脂肪性肝炎大鼠脂毒性及氧化应激的影响[J].中国中医药信息杂志,2018,25(1):48.[doi:10.3969/j.issn.1005-5304.2018.01.011]
 MA Yan-hua,YANG Shao-jun,SHI Xia,et al.Effects of Cigu Xiaozhi Pills on Lipotoxicity and Oxidative Stress in Rats with Non-alcoholic Steatohepatitis[J].zhongguo zhongyiyao xinxi zazhi,2018,25(1):48.[doi:10.3969/j.issn.1005-5304.2018.01.011]
[10]马燕花,师霞,韩涛,等.慈菇消脂丸对非酒精性脂肪性肝炎模型大鼠JNK1、p-c-Jun和Caspase-8表达的影响[J].中国中医药信息杂志,2019,26(9):55.[doi:10.3969/j.issn.1005-5304.2019.09.013]
 MA Yanhua,SHI Xia,HAN Tao,et al.Effects of Cigu Xiaozhi Pills on Expressions of JNK1, p-c-Jun and Caspase-8 in Non-alcoholic Steatohepatitis Model Rats[J].zhongguo zhongyiyao xinxi zazhi,2019,26(1):55.[doi:10.3969/j.issn.1005-5304.2019.09.013]

备注/Memo

基金项目:湖南省自然科学基金面上项目(2016JJ2096);湖南省卫生健康委员会科研计划(20201673)

更新日期/Last Update:

2020-12-18